May 19, 2023
National Institute of Dental and Craniofacial Research (NIDCR)
The purpose of this Notice is to inform potential applicants that the National Institute of Dental and Craniofacial Research (NIDCR) is participating, effective immediately, in the funding opportunity PAR-23-156 Lasker Clinical Research Scholars Program (Si2/R00 Clinical Trial Optional).
The following sections of PAR-23-156 have been updated to add the NIDCR specific information (changes shown in bold italics):
Components of Participating Organizations
NATIONAL INSTITUTES OF HEALTH (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
National Human Genome Research Institute (NHGRI)
National Institute on Aging (NIA)
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
National Institute on Deafness and Other Communication Disorders (NIDCD)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
National Institute of Environmental Health Sciences (NIEHS)
National Library of Medicine (NLM)
National Center for Complementary and Integrative Health (NCCIH)
National Cancer Institute (NCI)
National Institute of Dental and Craniofacial Research (NIDCR)
Assistance Listing Number(s)
93.398, 93.855, 93.847, 93.113, 93.233, 93.838, 93.837, 93.839, 93.840, 93.172, 93.213, 93.866, 93.879, 93.846, 93.173, 93.121
RESEARCH AREAS OF INTEREST
Participating NIH Institutes and Centers, and their preferred areas of clinical research interest, are provided below. Applicants are strongly encouraged to discuss their proposed research with a Scientific/Research Contact listed in Section VII, Agency Contacts.
National Cancer Institute (NCI):
Medical oncology, medical hematology-oncology, pediatric hematology/oncology, radiation oncology, surgical oncology, pathology, neuro-oncology, urology, myeloid malignancies, health disparities, data science and artificial intelligence. Specific areas within these categories include genitourinary oncology, lymphoid malignancies, neuro-oncology, immunotherapy (including cell therapy and transplant), women's cancers, aeoro-digestive cancers, molecular diagnostics, functional imaging.
Cancer etiology and prevention, cancer genetics, clinical epidemiology of cancer.
Cancer prevention including development and testing of interception agents (including small molecules, vaccines and biologics), novel and precision methods for screening, early detection, and management of average- and high-risk cohorts, early diagnostic biomarker development, behavioral cancer prevention interventions, and additional cancer prevention-oriented translational research.
National Heart, Lung, and Blood Institute (NHLBI):
Translational research aimed at developing new diagnostics and clinical therapeutics for heart, lung, and blood diseases.
Translational gene therapy research for heart lung and blood diseases.
Tumor immunotherapy and experimental stem cell transplantation.
Translational research in critical care medicine and sickle cell anemia.
National Human Genome Research Institute (NHGRI)
The National Human Genome Research Institute research areas of interest include the genetics, genomics and molecular biology of normal and abnormal human development.
National Institute on Aging (NIA):
Health Disparities.
National Institute of Allergy and Infectious Diseases (NIAID):
Clinical allergy/immunology, Clinical infectious diseases, Virology.
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS):
Rheumatology, dermatology, bone, joint, and skin research
National Institute on Deafness and Other Communication Disorders (NIDCD):
Normal and disordered processes of hearing, balance, taste, smell, and voice.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) :
Gastroenterology, nephrology, endocrinology.
National Institute of Environmental Health Sciences (NIEHS):
Environmental effects on human health, gene x environment interactions, inflammation/inflammatory disease, pulmonary/respiratory biology, OB/GYN/reproductive biology/reproductive endocrinology, epidemiology/population science, rheumatology/immune mediated disease.
National Library of Medicine (NLM):
Computational approaches to integrating, mining and tracking data relevant to public health surveillance, particularly for particularly underserved populations.
Natural language processing, presentation and understanding of consumer/patient health information.
Artificial intelligence and machine learning to support automated decision making, genome-phenome data linking, bias reduction and image-based diagnostics for health care.
Computational modeling of biological processes with focus on their impact on disease.
National Center for Complementary and Integrative Health (NCCIH):
Epidemiological, clinical, and translational research focusing on the role of the nervous system, other physiological systems, and psychosocial factors in perceiving, modifying, and managing pain, including approaches that apply to the concept of whole person health and health restoration.
National Institute of Dental and Craniofacial Research (NIDCR):
Craniofacial anomalies, including genetics, pathophysiology, and surgical therapies
Craniofacial and salivary gland regenerative medicine, tissue engineering, stem cell biology
Craniofacial and dental developmental biology and human genetics
Metabolic bone disease
Scientific/Research Contact(s)
Charles R. Dearolf, Ph.D.
Director, Program Development and Support
Office of Intramural Research
Telephone: 301-402-1225
Email: [email protected]
Thomas Misteli, Ph.D. (oncology)
National Cancer Institute (NCI)
Telephone: 240-760-6400
Email: [email protected]
Stephen J. Chanock, M.D. (cancer epidemiology and genetics)
National Cancer Institute (NCI)
Telephone: 240-276-7150
Email: [email protected]
Sharon Savage, M.D. (cancer epidemiology and genetics)
National Cancer Institute (NCI)
Telephone: 240-276-7241
Email: [email protected]
Jessica Faupel-Badger, Ph.D. (cancer prevention)
National Cancer Institute (NCI)
Telephone: 240-276-5215
Email: [email protected]
Angela Prazak
National Institute on Aging (NIA)
Telephone: 667-205-2212
Email: [email protected]
Luigi Ferrucci, MD, Ph.D.
National Institute on Aging (NIA)
Telephone: 410-558-8110
Email: [email protected]
Janet Hall, M.D.
National Institute of Environmental Health Sciences (NIEHS)
Telephone: 984-287-3647
Email: [email protected]
Richard Childs, MD
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-827-1396
Email: [email protected]
Steven Holland, M.D.
National Institute of Allergy and Infectious Disease (NIAID)
Telephone: 301-402-7684
Email: [email protected]
Benjamin Solomon, MD
National Human Genome Research Institute (NHGRI)
Telephone: 301-402-8824
Email: [email protected]
Bettie J. Graham, Ph.D.
National Human Genome Research Institute
Telephone: 301-496-7531
Email: [email protected]
Lisa Cunningham, Ph.D.
National Institute on Deafness and Other Communication Disorders (NIDCD)
Phone: 301-443-2766
Email: [email protected]
William Dahut (oncology)
National Cancer Institute (NCI)
Telephone: 301-496-4251
Email: [email protected]
Stephen J. Chanock (epidemiology)
National Cancer Institute (NCI)
Telephone: 240-276-7150
Email: [email protected]
Lanay M. Mudd, Ph.D., FACSM
National Center for Complementary and Integrative Health (NCCIH)
Phone: 301-594-9346
Email: [email protected]
Valerie Florance
National Library of Medicine (NLM)
Telephone: 301-496-4621
Email: [email protected]
John O'Shea
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Telephone: 301-496-2612
Email: [email protected]
Michael Krause
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Telephone: 301-402-4633
Email: [email protected]
Janice Lee, DDS, PhD, FACS
National Institute of Dental and Craniofacial Research (NIDCR)
Telephone: 301-827-1647
Email: [email protected]
Lynn Mertens King, PhD
National Institute of Dental and Craniofacial Research (NIDCR)
Telephone: 301-594-5006
Email: [email protected]